Cargando…
Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis
BACKGROUND: Early diagnosis of bacterial sepsis in neonates is hampered by non-specific symptoms and the lack of rapid responding laboratory measures. The biomarker soluble CD14 subtype (sCD14-ST) seems promising in the diagnostic process of neonatal sepsis. In order to evaluate the differences in d...
Autores principales: | van Maldeghem, Iris, Nusman, Charlotte M., Visser, Douwe H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547508/ https://www.ncbi.nlm.nih.gov/pubmed/31159729 http://dx.doi.org/10.1186/s12865-019-0298-8 |
Ejemplares similares
-
The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models
por: Shirakawa, K, et al.
Publicado: (2010) -
New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004) -
The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis
por: Zhang, Xin, et al.
Publicado: (2015) -
Evaluation of a soluble CD14 subtype in patients with surgical sepsis
por: Fukui, Y
Publicado: (2012) -
Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates
por: Pugni, Lorenza, et al.
Publicado: (2015)